Navigation Links
Novagali Pharma Announces the Launch of Cationorm(R)
Date:4/9/2008

ration of ophthalmic medicines. It is based on the electrostatic attraction that occurs between the droplets of a positively-charged emulsion and the negatively charged cells of the ocular surface, including cornea and conjunctiva.

The commercial launch of Cationorm(R) in Europe and in the United States by the end 2008, where the product complies with the OTC status, is a major event for the development of Novagali Pharma. <>, said Jerome Martinez, CEO of Novagali Pharma.

Cationorm(R) is a medical device available in France since April 2008. The product is unpreserved and packaged in box of 30 sterile single vials.

A propos de Novagali Pharma : http://www.novagali.com

Novagali Pharma is an ophthalmic pharmaceutical company based in the Genopole biocluster in Evry (France) that develops and commercializes innovative products. Thanks to its proprietary technology platforms Novasorb(R) and Eyeject(R), the company has developed a broad pipeline of 7 innovative products addressing main ocular conditions as well as orphan diseases. Most advanced products include Vekacia(R), an orphan product for treatment of vernal keratoconjunctivitis, Cyclokat(R), a product for the treatment of moderate-to-severe dry eye syndrome and Cortiject(R) for the treatment of diabetic retinopathies. Cationorm(R), indicated for dry eye symptoms is commercialized in France since April 2008. Founded in 2000, Novagali Pharma has 50 employees.


'/>"/>
SOURCE Novagali Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... This report analyzes the worldwide markets for Bioinformatics ... and Biocontent. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... World. Annual estimates and forecasts are provided for the period ... for these markets. Market data and analytics are derived from ...
(Date:9/16/2014)... --The emerging field of molecular electronics could take ... enabling the construction of tiny circuits from molecular ... would take on the roles currently played by ... of researchers from five Japanese and Taiwanese universities ... small-scale electronics: a molecule called picene. In a ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 ... world’s most efficient method for delivering dissolved gases ... Equipment Inc. as a manufacturer’s representative firm ... gas dissolution products for municipal water and wastewater ... Quebec. , H2Flow was founded in 1992 and ...
(Date:9/16/2014)... East Longmeadow, MA (PRWEB) September 16, 2014 ... the appointment of Brian Highley as CEO of CIRTEC. ... at this exciting point for the Company.” noted Brian ... and operational performance while sustaining strong organic growth over ... accelerate CIRTEC’s growth by continuing to improve and expand ...
Breaking Biology Technology:Global Bioinformatics Industry 2Global Bioinformatics Industry 3Global Bioinformatics Industry 4Global Bioinformatics Industry 5Global Bioinformatics Industry 6Global Bioinformatics Industry 7Global Bioinformatics Industry 8Global Bioinformatics Industry 9Global Bioinformatics Industry 10Global Bioinformatics Industry 11Global Bioinformatics Industry 12Global Bioinformatics Industry 13Global Bioinformatics Industry 14Global Bioinformatics Industry 15Global Bioinformatics Industry 16Global Bioinformatics Industry 17Global Bioinformatics Industry 18Global Bioinformatics Industry 19Global Bioinformatics Industry 20Global Bioinformatics Industry 21Global Bioinformatics Industry 22Global Bioinformatics Industry 23The future face of molecular electronics 2BlueInGreen® Expands into Canada – Signs Representative Agreement with H2Flow Equipment Inc. 2
... recent salmonella outbreaks in the United States: ground turkey; ... the list goes on, according to the U.S. Centers ... long, thanks to a promising new biosensor nanotechnology that ... food or animals reach the marketplace. In the AIP,s ...
... Life Technologies Corporation (NASDAQ: LIFE ) today ... Non-GAAP revenue for the third quarter was $929 million, an ... the third quarter of 2010. Excluding the impact of currency, ... the same period of the prior year. (Logo: ...
... SAN DIEGO, Oct. 25, 2011 Conatus Pharmaceuticals Inc. announced ... CTS-1027 in HCV patients.  This decision follows reports of laboratory ... participants. The top priority of Conatus is patient ... this study.  Conatus is conducting a thorough review of the ...
Cached Biology Technology:Life Technologies Announces Third Quarter 2011 Results 2Life Technologies Announces Third Quarter 2011 Results 3Life Technologies Announces Third Quarter 2011 Results 4Life Technologies Announces Third Quarter 2011 Results 5Life Technologies Announces Third Quarter 2011 Results 6Life Technologies Announces Third Quarter 2011 Results 7Life Technologies Announces Third Quarter 2011 Results 8Life Technologies Announces Third Quarter 2011 Results 9Life Technologies Announces Third Quarter 2011 Results 10Life Technologies Announces Third Quarter 2011 Results 11Life Technologies Announces Third Quarter 2011 Results 12Life Technologies Announces Third Quarter 2011 Results 13Life Technologies Announces Third Quarter 2011 Results 14Life Technologies Announces Third Quarter 2011 Results 15Life Technologies Announces Third Quarter 2011 Results 16Life Technologies Announces Third Quarter 2011 Results 17
(Date:9/16/2014)... LINCOLNSHIRE, Ill. , Sept. 16, 2014 ... asked to make important decisions about their 2015 benefits. ... retirement and health solutions business of Aon ... expected to take a more proactive role in managing ... more important than ever for individuals to understand how ...
(Date:9/15/2014)... study indicates that lowland tapir populations may continue to ... Researchers from the Office National de la Chasse ... San Diego Zoo Global reviewed data retrieved from camera ... four years and compared this data to current harvest ... on hunting tapirs in French Guiana," said Matthias Tobler, ...
(Date:9/15/2014)... vital source of energy for both plants and animals ... into the cell could lead to the design of ... the amount of fruits and vegetables farmers are able ... of these "pathways" into the cell by piecing together ... of spider silk. , To determine the size, shape ...
Breaking Biology News(10 mins):Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 2Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 3Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 4Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 5Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 6Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 7X-rays unlock a protein's SWEET side 2X-rays unlock a protein's SWEET side 3
... cells called macrophages may be a source of inflammatory ... the most common and effective treatment for prostate cancer, ... University of California, San Diego (UCSD) School of Medicine. ... for the physiological function and growth of the prostate ...
... Groundbreaking research published today could revolutionise the way drugs ... sector, say its authors. , The University of Manchester ... unique insight into the working of enzymes ?biological molecules ... When these chemical reactions go wrong they can lead ...
... new University of Colorado at Boulder study shows that ... have more impaired thinking and memory skills than they ... 24 hours. , The study showed test subjects had ... the groggy period upon awakening known as sleep inertia, ...
Cached Biology News:Macrophage signaling may affect hormone resistance in prostate tumors 2Research could lead to better drugs and whiter whites 2Morning grogginess more debilitating than sleep deprivation, according to CU-Boulder study 2Morning grogginess more debilitating than sleep deprivation, according to CU-Boulder study 3
... Fully automated microarray slide processing offering ... The trend to miniaturization, automation and ... a powerful tool with many applications ... These applications range from gene expression ...
... The user-friendly Eppendorf Thermomixer R offers ... that require shaking, heating, and cooling. ... expanded its application and temperature control ... each accommodate 24 micro test tubes, ...
... DetectorTM Microarray Dot Blot Kits overcome this ... quantitation over a wide range in low-density ... detection. They are ideal for performing ... of samples for the presence of low ...
... is a high quality microarray scanner based on ... rejection and spatial resolution. The DNAscope LM ... cost microarray scanner that is upgradeable to a ... Features: Includes control module (computer), ...
Biology Products: